Posts by J-Star Research
Porton Pharma Solutions Ltd. celebrates its 15th Anniversary
Porton Pharma Solutions Ltd. celebrates its 15th Anniversary
Read MoreCenter for Pharma Crystallization at J-STAR Research Announces Consulting Partnership with Professor Kevin Roberts
Bringing in the best minds, knowledge and methodologies in the field to speed up solving challenging problems in new drug development, CfPC (Center for Pharma Crystallization) at J-Star Research is…
Read More2020 Pharmaceutical Crystallization Summit
Cranbury, N.J., June 26, 2020 – J-Star Research, a leading provider of services in complex organic synthesis and crystallization for a variety of pharmaceutical clients globally, today launched its 1st…
Read MoreCenter for Pharma Crystallization at J-Star Research Annual Conference
Crystallization technologies are bridges between drug substances and drug products enabling consistent safety and efficacy profiles of small molecule based medicines. To fully utilize existing tools and develop better new…
Read MoreWebinar series on Solid Formulations
We are pleased to announce a 7-week #webinar series on #solid #formulations, organized by XtalPi Inc. and J-STAR Research, Inc. Leading experts will present insights into R&D workflows, strategies, and best practices to implement…
Read MoreJ-Star Research Structural Elucidation and NMR Expansion
J-Star Research has recently established significant impurity isolation and structural elucidation capabilities. The R&D team is comprised of experts in identifying and characterizing low levels (e.g. 0.1%) of impurities in…
Read MoreJ-Star Research, Inc launches new website
South Plainfield, NJ., March 12, 2020 — J-Star Research, Inc, the leading Contract Research Organization focused on Small Molecule Process Research and Crystallization R&D, is proud to announce the launch…
Read MorePorton and Xtalpi Announced Strategic Cooperation
March 10, 2020, Chongqing • China–XtalPi Inc.(hereafter referred to as XtalPi), an algorithm-driven AI pharmaceutical technology company, announced the signing of a strategic cooperation agreement today. The two parties aim to…
Read MorePorton Completes Acquisition of J-STAR Research
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization （CDMO） serving the global pharmaceutical industry, today announced that Porton USA,…
Read MorePorton USA to Acquire J-STAR Research to Expand Its Research and Development Capabilities
CRANBURY, N.J., Jan. 27, 2017 /PRNewswire/ — Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a…
Read More